November 25, 2022 – S’pore firm comes up with world’s first molecular blood test for early detection of gastric cancer

SINGAPORE – When Associate Professor Too Heng-Phon was about to start biotechnology firm Mirxes back in 2010, he asked several of his PhD students to join him, but also warned them that it would be tough going.

Two of them decided to help set up the home-grown biotech firm, which went on to develop test kits that use blood-based microRNAs (miRNAs) to serve as biomarkers for early detection of cancers.